logo

For the Inventor, By the Inventor

Castres, France

Dennis C Bigg

USPTO Granted Patents = 23

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 143(Granted Patents)


Location History:

  • Marsillargues, FR (1982)
  • Paris, FR (1985)
  • Jouy en Josas, FR (1981 - 1986)
  • Castres, FR (1990 - 1997)

Company Filing History:

goldMedal12 out of 252 
 
Synthelabo
 patents
silverMedal11 out of 266 
 
Pierre Fabre Medicament
 patents

Years Active: 1981-1997

Loading Chart...
23 patents (USPTO):Explore Patents
1. 5633255 - 1,2-dihydro-2-oxo-3-aminoquinoxaline derivatives, their preparation and (1997-05-27),
2. 5620985 - Antimitotic binary alkaloid derivatives from catharanthus roseus (1997-04-15),
3. 5385931 - Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their (1995-01-31),
4. 5308844 - Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazin-4-ones and (1994-05-03),
5. 5288758 - New urea derivatives, their preparation and their application in therapy (1994-02-22),
6. 5286735 - Derivatives of 4-aminomethylpiperidine, their preparation and their use (1994-02-15),
7. 5254554 - 3-hydroxy-substituted-1-phenyl-1,4-dihydro-4-oxopyridazines and (1993-10-19),
8. 5198441 - Derivatives of 1,2-dihydro 2-oxo quinoxalines, their preparation and (1993-03-30),
9. 5192763 - [(1-arylpyrrolidin-2-yl)methyl]piperazine derivatives, their preparation (1993-03-09),
10. 5182273 - Spirocyclic N, O derivatives of cyclotriphosphazenes and their use in (1993-01-26),
11. 5081128 - 2,3-dihydro-1H-isoindole derivatives and their application in therapy (1992-01-14),
12. 5059599 - Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their (1991-10-22),
13. 5034541 - Method of preparing (1991-07-23),
14. 4977159 - 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole (1990-12-11),
15. 4904684 - 2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1 (1990-02-27),

Title: Pioneering Inventor Dennis C Bigg: Crafting a Legacy of Innovation

Introduction: Dennis C Bigg's unwavering dedication to innovation and his relentless pursuit of excellence have cemented his status as a pioneering inventor in the realm of technology. His ingenuity continues to serve as a beacon of inspiration for future generations of inventors, urging them to push boundaries and devise solutions with a lasting societal impact.

Latest Patents: Among his vast array of 23 patents, some of Dennis C Bigg's latest groundbreaking inventions include the development of 1,2-dihydro-2-oxo-3-aminoquinoxaline derivatives and antimitotic binary alkaloid derivatives sourced from catharanthus roseus.

Career Highlights: Throughout his illustrious career, Dennis C Bigg has left an indelible mark on the industry through his work at renowned companies such as Synthelabo and Pierre Fabre Medicament. His innovative spirit and forward-thinking approach have propelled him to the forefront of technological advancement.

Collaborations: Collaborating with esteemed colleagues like Mireille Sevrin and Claude C Morel, Dennis C Bigg has fostered a culture of creativity and collaboration, leading to the development of cutting-edge inventions that have revolutionized the field of technology.

Conclusion: Dennis C Bigg's exceptional contributions to the world of innovation stand as a testament to his unwavering commitment to pushing boundaries and reshaping the technological landscape. His legacy serves as a beacon of inspiration for aspiring inventors, encouraging them to embrace ingenuity and drive positive change through their inventive pursuits.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…